简介:美国和加拿大罗氏制药公司告诫医务人员:利福平(rifampicin,抗结核病药)和利托那韦/沙奎那韦(ritonavir/saguinavir,用于HIV治疗)联合应用会导致肝炎和转氨酶明显升高。目前,利福平已禁止与沙奎那韦合用,因为二者有药动学相互作用。研究人员进行了一项28天随机研究,共有28名健康受试者接受利福平600mg,1次/d,利托那韦/沙奎那韦100mg/1000mg,2次/d。11人(39.3%)出现明显的肝细胞毒性,部分病人转氨酶水平升高,大于正常值上限20倍,其中1人因转氨酶升高而住院。停药后,
简介:目的观察阿昔洛韦治疗小儿水痘的临床疗效和安全性。方法120例水痘患儿随机分为2组,治疗组60例,用阿昔洛韦注射液每天10mg/kg体重,每日1次静脉滴注,疗程4~6d;对照组60例.用三氟唑核苷(利巴韦林)注射液每天10~15mg/kg体重,每日1次静脉滴注,疗程为5~7d,其他治疗方法相同。结果治疗组平均痊愈时间4.3±0.5d,对照组平均痊愈时间5.8±0.6d,两组比较,差异有显著性(P〈0.05),治疗组痊愈率为100%,对照组痊愈率为96.7%,两组疗效比较盖异无显著性。且两组治疗前后患儿血尿常规、肝肾功能检查未见异常。结论阿昔洛韦治疗小儿水痘疗效高,安全可靠,可供临床使用。
简介:ToinvestigatestheclinicalsingsandthepathologymorphologicchangesofthehearttissueofacasewiththecardiacWegener'sgranulomatosis.MethodsTheclinicalwithwasexaminedECGandlaboratory.ThepathologysamplesweresectionedroutineparaffinandstainedwithHE、PAS、AB-PASandcellulosestainingandobservedwithlightmicroscope.ResultsTheECGwasmanifestedacutemyocardialinfarctionintheleftlateralwallandthebloodexaminationwereoftheheart,andthebloodexaminationweremanifestedliftpedigreefermentofmyocardium.Thepathologysectionsweremanifestednecrosislargeareaperforationwallofthemyocardialandbecamegranulomadiffusible.Endocarditis,necroticvesselitisandthrombuscouldbefoundandthatthecoronaryisnotembolism.Similarlesionscouldbefoundandaliketotheheartintheleftlungparenchymaandtheperipheralzoneoftracheaandbloodvessel.HistochemicalexaminationwithPASandAB-PASshowedcryptococcusnegativeintheheartandlungs.Cellulosestainingwaspositivereactioninthevascularwall.Antineutrophilcytoplasmicantibody(ANCA)wasnegativeinthebloodfromtheheart.ConclusionCardiacWegener'sgranulomatosisisrare.Clinicalsingstheeversosimilartoacutemyocardialinfarctionandthatisnotallbutdifferentiationandprognosisandunfavorableoftheevercuch.